Our Approach to Sexual Health
Sexual health is a core component of overall well-being, yet it is often overlooked or minimized in traditional care.
At Harmony Health & Hormones, concerns related to libido, arousal, and sexual function are approached with clinical precision and without dismissal.
Care is individualized and considers hormonal, neurological, relational, and metabolic factors. The goal is to restore desire, improve function, and support a sense of connection with your body.
Understanding Low Libido
Low libido is rarely caused by a single factor.
It is typically the result of interacting systems, including:
- hormonal signalling
- brain neurotransmitters
- stress and nervous system tone
- metabolic health
- relationship and psychological context
This is why quick fixes are often ineffective — meaningful improvement requires understanding the full picture.
Common Signs & Concerns
Desire & Interest
- reduced or absent interest in sex
- feeling disconnected from desire
- lack of spontaneous or responsive libido
Arousal & Physical Response
- difficulty becoming aroused
- reduced sensation
- decreased lubrication
Sexual Function
- discomfort or pain with intimacy
- difficulty achieving orgasm
- changes in sexual response
Associated Patterns
- fatigue or burnout
- mood changes or anxiety
- body image changes
- relationship strain related to intimacy
What Is Happening Physiologically
Sexual function is influenced by multiple systems working together:
Hormonal Factors
- Testosterone plays a key role in desire, motivation, and sexual signaling in the brain
- Estradiol supports vaginal tissue health, blood flow, and lubrication
- Progesterone influences sleep and nervous system regulation
Even subtle shifts can affect libido.
Neurotransmitters
- Dopamine supports motivation and desire
- Serotonin can dampen libido when elevated (including with some medications)
- GABA and stress pathways influence arousal and relaxation
Genitourinary Changes (GSM)
Reduced estrogen at the tissue level can lead to:
- vaginal dryness
- discomfort with intimacy
- decreased elasticity and blood flow
Metabolic & Thyroid Influence
Insulin resistance, thyroid dysfunction, and chronic stress can all impact energy, mood, and sexual function.
Common Contributing Factors
Low libido may be influenced by:
- perimenopause or menopause
- low or suboptimal testosterone
- thyroid dysfunction
- PCOS or metabolic dysfunction
- antidepressant use (SSRIs/SNRIs)
- chronic stress or burnout
- sleep disruption
Often, multiple factors are present simultaneously.
How We Assess Sexual Health
Assessment is comprehensive and individualized.
This may include:
- detailed symptom history
- hormonal evaluation (estradiol, progesterone, testosterone, SHBG)
- thyroid assessment
- metabolic markers
- review of medications and contributing factors
Care focuses on identifying patterns rather than isolating a single cause.
How We Treat Low Libido
Treatment is tailored to your physiology and goals and may include:
- hormonal support when indicated
- targeted treatment for genitourinary concerns
- medication review and adjustment
- nervous system and lifestyle support
A Continuity Care Model
Sexual health improves over time with the right support.
Your care includes:
- prescriptions as clinically appropriate
- ongoing follow-up
- adjustment based on response
- integration across hormonal systems
This allows for meaningful and sustained improvement.
Expected Outcomes
With appropriate care, many women experience:
- return of sexual desire
- improved arousal and responsiveness
- reduced discomfort with intimacy
- improved confidence and body connection
- enhanced relationship satisfaction
- improved overall quality of life
Book a Consultation
Low libido is common and treatable.
A comprehensive, personalized approach can help restore function and improve how you feel in your body.
Virtual care is available across Ontario.
References
Parish, S. J., et al. (2021). International Society for the Study of Women’s Sexual Health (ISSWSH) guidelines.
Davis, S. R., et al. (2019). Testosterone therapy in women: Global consensus position statement.
Kingsberg, S. A., et al. (2017). Female sexual dysfunction and treatment approaches.
Goldstein, I., et al. (2017). Vulvovaginal atrophy and sexual health.
Get started
Personalized Hormone Care, Wherever You Are in Ontario
Now accepting new patients. Every appointment is virtual.
